Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative,...

por Perkhofer, L., Berger, A. W., Beutel, A. K., Gallmeier, E., Angermeier, S., Fischer von Weikersthal, L., Goetze, T. O., Muche, R., Seufferlein, T., Ettrich, T. J.
Publicado 2019

Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

por Al‐Batran, Salah‐Eddin, Moorahrend, Enno, Maintz, Christoph, Goetze, Thorsten O., Hempel, Dirk, Thuss‐Patience, Peter, Gaillard, Vincent E., Hegewisch‐Becker, Susanna
Publicado 2020

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in...

por Goetze, Thorsten O., Bechstein, Wolf O., Bankstahl, Ulli Simone, Keck, Tobias, Königsrainer, Alfred, Lang, Sven A., Pauligk, Claudia, Piso, Pompiliu, Vogel, Arndt, Al-Batran, Salah-Eddin
Publicado 2020

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology

por Al-Batran, S.-E., Mueller, D.W., Rafiyan, M.-R., Kiselicki, D., Atmaca, A., Habibzada, T., Mueller, C., Brignone, C., Triebel, F., Loose, M., Schaaf, M., Sookthai, D., Eickhoff, R., Jaeger, E., Goetze, T.O.
Publicado 2023

Colorectal Cancer Organoid–Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses

por Farin, Henner F., Mosa, Mohammed H., Ndreshkjana, Benardina, Grebbin, Britta M., Ritter, Birgit, Menche, Constantin, Kennel, Kilian B., Ziegler, Paul K., Szabó, Lili, Bollrath, Julia, Rieder, Dietmar, Michels, Birgitta E., Kress, Alena, Bozlar, Müge, Darvishi, Tahmineh, Stier, Sara, Kur, Ivan-Maximilano, Bankov, Katrin, Kesselring, Rebecca, Fichtner-Feigl, Stefan, Brüne, Bernhard, Goetze, Thorsten O., Al-Batran, Salah-Eddin, Brandts, Christian H., Bechstein, Wolf O., Wild, Peter J., Weigert, Andreas, Müller, Susanne, Knapp, Stefan, Trajanoski, Zlatko, Greten, Florian R.
Publicado 2023

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

por Heitmann, Jonas S., Tandler, Claudia, Marconato, Maddalena, Nelde, Annika, Habibzada, Timorshah, Rittig, Susanne M., Tegeler, Christian M., Maringer, Yacine, Jaeger, Simon U., Denk, Monika, Richter, Marion, Oezbek, Melek T., Wiesmüller, Karl-Heinz, Bauer, Jens, Rieth, Jonas, Wacker, Marcel, Schroeder, Sarah M., Hoenisch Gravel, Naomi, Scheid, Jonas, Märklin, Melanie, Henrich, Annika, Klimovich, Boris, Clar, Kim L., Lutz, Martina, Holzmayer, Samuel, Hörber, Sebastian, Peter, Andreas, Meisner, Christoph, Fischer, Imma, Löffler, Markus W., Peuker, Caroline Anna, Habringer, Stefan, Goetze, Thorsten O., Jäger, Elke, Rammensee, Hans-Georg, Salih, Helmut R., Walz, Juliane S.
Publicado 2023

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic...

por Al-Batran, Salah-Eddin, Goetze, Thorsten O., Mueller, Daniel W., Vogel, Arndt, Winkler, Michael, Lorenzen, Sylvie, Novotny, Alexander, Pauligk, Claudia, Homann, Nils, Jungbluth, Thomas, Reissfelder, Christoph, Caca, Karel, Retter, Steffen, Horndasch, Eva, Gumpp, Julia, Bolling, Claus, Fuchs, Karl-Hermann, Blau, Wolfgang, Padberg, Winfried, Pohl, Michael, Wunsch, Andreas, Michl, Patrick, Mannes, Frank, Schwarzbach, Matthias, Schmalenberg, Harald, Hohaus, Michael, Scholz, Christian, Benckert, Christoph, Knorrenschild, Jorge Riera, Kanngießer, Veit, Zander, Thomas, Alakus, Hakan, Hofheinz, Ralf-Dieter, Roedel, Claus, Shah, Manish A., Sasako, Mitsuru, Lorenz, Dietmar, Izbicki, Jakob, Bechstein, Wolf O., Lang, Hauke, Moenig, Stefan P.
Publicado 2017